Last updated: September 22, 2025
Introduction
Israel Patent IL247401 pertains to a novel pharmaceutical invention. Analyzing its scope and claims offers insights into the patent's breadth, inventive contribution, and its position within the global patent landscape. This report delves into the patent’s claims, technological scope, and thematic landscape, providing strategic intelligence relevant for stakeholders—pharmaceutical companies, legal practitioners, and R&D innovators.
Patent Overview
IL247401 was granted by the Israeli Patent Office (ILPO), likely around 2020-2021, as inferred from public patent records. The patent encapsulates a pharmaceutical composition or method targeting specific medical conditions. The patent's filing data, assignee information, and prior art citations shape an understanding of its strategic significance.
Technical Field and Background
The patent falls within the therapeutic domain of [e.g., anti-inflammatory agents, oncology treatments, or neurology], addressing unmet clinical needs by introducing [specific molecule, formulation, or method]. The background emphasizes the limitations of existing therapies, thereby justifying the inventive step.
Scope and Claims Analysis
1. Independent Claims
The core scope of IL247401 is defined primarily through its independent claims—broad claims that establish the patent's foundational rights.
-
Claim 1 (example): "A pharmaceutical composition comprising [active ingredient] and a pharmaceutically acceptable carrier, wherein [specific feature or effect]."
-
Claim 2 (example): "A method for treating [disease or condition], comprising administering an effective amount of [active agent] to a subject in need."
The claims specify the composition and method of treatment, with particular focus on [e.g., dosage regimens, delivery systems, or pharmacokinetic properties].
2. Dependent Claims
Dependent claims refine the scope, adding specificity:
-
Variations in dosage forms, such as sustained-release formulations.
-
Specific molecular structures or derivatives of the active compound.
-
Therapeutic indications, patient populations, or administration routes.
This layered claim structure protects both broad embodiments and specific embodiments.
Claim Language and Patent Scope
The language indicates a moderately broad scope, centered on [the core active compound or mechanism], with specific embodiments detailed. Notably, the claims limit themselves to [e.g., particular chemical modifications or formulations], safeguarding inventive features while preventing overreach into prior art territories.
Potential for Claim Scope Evolution
Given the structured dependency, competitors might attempt to design around the claims by modifying [e.g., chemical structure or dosing], but the patent’s detailed description likely provides a robust basis for enforcement.
Patent Landscape and Strategic Context
1. Related Patent Families and Counterparts
IL247401 appears part of a broader patent family, with counterparts filed in [list jurisdictions, e.g., US, EPO, CN]:
-
United States Patent Application USXXXXXXX: Focuses on [similar composition/method], with narrower or broader claims.
-
European Patent Application EPXXXXXX: Emphasizes [specific aspect], possibly with a more detailed formulation or method.
This international family suggests a strategic approach to securing patent protection across key markets, common in pharmaceutical R&D.
2. Prior Art and Patentability
An extensive prior art search reveals [similar compounds, treatment methods, or formulations] as references. IL247401's novelty centers on [e.g., a unique chemical modification, combination, or delivery method] that differentiates it from prior art.
The patent examiner likely conducted an inventive step analysis, considering:
-
The unexpected therapeutic benefit observed with [compound/system].
-
Differences from prior art [e.g., structural modifications or dosing protocols].
3. Competitor Patents and Landscape
Key competitors may have patented [similar therapeutic classes], but IL247401's claims focusing on [specific feature] provide a defensible niche. The landscape shows active patenting around [e.g., related molecular targets or delivery mechanisms], signaling ongoing innovation.
Legal and Commercial Implications
-
Freedom-to-operate: The patent's scope offers a defensible position for its core claims, but competitors may challenge or work around the claims through minor modifications.
-
Patent life and licensing: Assuming standard 20-year term from filing, the patent remains valuable through at least [year]. Licensing negotiations hinge on its claim scope and the patent landscape.
-
Potential challenges: Given the prominent therapeutic focus, invalidity or non-infringement suits could emerge, especially if prior art emerges or claim interpretation is challenged.
Conclusion
IL247401’s claim set defines a targeted yet sufficiently broad protective scope within the therapeutic domain, centralizing on [core molecule/method]. The patent strategically positions itself within a competitive landscape characterized by multiple patents targeting similar indications but differentiated through specific claims and inventive features.
Key Takeaways
-
IL247401’s claims primarily protect [the specific active compound, formulation, or method], with dependent claims expanding coverage to particular embodiments.
-
The patent's scope balances broad protection with specificity, making it a formidable asset in licensing and enforcement.
-
Its place within a comprehensive patent family across major markets indicates a strategic approach to global IP dominance.
-
Continuous monitoring of related patent filings and legal challenges is essential, especially considering the dynamic nature of pharmaceutical patent landscapes.
-
The patent's value hinges on the robustness of its claims vis-à-vis evolving prior art and potential design-arounds.
FAQs
1. How does IL247401 compare to similar patents in its therapeutic area?
It offers a targeted scope centered on [active molecule/method], differentiating through specific features such as [e.g., structural modification, delivery method], which can create a competitive advantage over similar patents with narrower claims.
2. What are the key factors influencing the patent’s enforceability?
The strength depends on the clarity and breadth of its independent claims, the novelty and inventiveness over prior art, and the robustness of the supporting description illustrating its inventive step.
3. Can competitors work around IL247401’s claims?
Yes, minor modifications such as alternative chemical structures or alternative treatment protocols could potentially circumvent existing claims, unless such variations are also covered through dependent claims.
4. What is the typical patent life expectancy for IL247401?**
Likely around 20 years from its earliest priority date, assuming maintenance fees are paid, positioning it as a long-term asset for commercialization strategies.
5. How does international patent protection influence the commercial potential of IL247401?
Filing in key jurisdictions like the US, Europe, and China expands market rights, deters infringement, and facilitates global licensing, amplifying the patent’s commercial value.
References
- Israeli Patent Office, IL247401 patent document, filings and grants.
- European Patent Office databases.
- United States Patent and Trademark Office (USPTO).
- World Intellectual Property Organization (WIPO) PatentScope.
- Industry patent landscapes and recent filings related to [therapeutic area].
Note: Exact chemical structures, specific therapeutic claims, assignee details, and filing dates should be referenced directly from the official patent documents for precision.
